OGI250117C4000
- 0.00
- 0.000.00%
OrganiGram Newsroom
CCORF Maintains OrganiGram(OGI.US) With Buy Rating, Maintains Target Price $2.18
Haywood Maintains OrganiGram(OGI.US) With Buy Rating, Raises Target Price to $3
A. G. P. Maintains OrganiGram(OGI.US) With Buy Rating, Cuts Target Price to $2.95
Analysts Offer Insights on Healthcare Companies: UniQure (QURE), Nyxoah (NYXH) and OrganiGram Holdings (OGI)
Haywood Reaffirms Their Buy Rating on OrganiGram Holdings (OGI)
Organigram Holdings Inc. Price Target Cut to C$3.15/Share From C$3.60 by Canaccord Genuity
Organigram Holdings Inc. Is Maintained at Speculative Buy by Canaccord Genuity
CCORF Maintains OrganiGram(OGI.US) With Buy Rating, Cuts Target Price to $2.22
CCORF Maintains OrganiGram(OGI.US) With Buy Rating, Raises Target Price to $2.62
Organigram Holdings Inc. Price Target Raised to C$3.60/Share From C$3.25 by Canaccord Genuity
Analysts' Top Healthcare Picks: OrganiGram Holdings (OGI), Plus Therapeutics (PSTV)
Analysts Are Bullish on These Healthcare Stocks: Tonix Pharma (TNXP), OrganiGram Holdings (OGI)
Organigram Holdings (TSE:OGI) Plunges With Plans to Enter US Market
Buy Rating Affirmed for OrganiGram Holdings Amid Strong Profit Margins and Strategic Market Positioning
Jefferies Reaffirms Their Buy Rating on OrganiGram Holdings (OGI)
Analysts Offer Insights on Healthcare Companies: OrganiGram Holdings (OGI), Camurus AB (OtherCAMRF) and CSL (OtherCMXHF)
OrganiGram Holdings (OGI) Receives a Buy From Jefferies
OrganiGram Holdings (OGI) Receives a Buy From Jefferies
Jefferies Reaffirms Their Buy Rating on OrganiGram Holdings (OGI)
Analysts Offer Insights on Healthcare Companies: United Therapeutics (UTHR), OrganiGram Holdings (OGI) and Passage Bio (PASG)